Skip to content

Treating Preterm Labor by Nifedipine or Magnesium sulfate

Nifedipine Compared to Magnesium sulfate for Treating Preterm Labor

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013090914603N1
Enrollment
100
Registered
2013-10-22
Start date
2003-04-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

preterm labor. Preterm labour without delivery

Interventions

Intervention 1: Nifedipine is initiated with a 30-mg ( 10 mg/20 min capsule) and then nifedipine maintenance dose is 10 mg every six hours. Intervention 2: Group with magnesium sulfate are initiated
Treatment - Drugs
Nifedipine is initiated with a 30-mg ( 10 mg/20 min capsule) and then nifedipine maintenance dose is 10 mg every six hours.
Group with magnesium sulfate are initiated with 10 g (I.V) and then 5 g (I.M) every 4 hours.

Sponsors

Vice-Chancellor for research affairs
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: gestations 24-37 week ; presence of 4 uterine contractions or more over 30 minutes; cervical changes 0-4 cm; effacement of at least 50%. Exclusions criteria: cervical dilatation >5 cm; medical complications with tocolysis like severe preeclampsia; maternal cardiac or liver diseases.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Prolongation of pregnancy. Timepoint: day of hospitalization until the 7th day. Method of measurement: Physical exam.;Treatment failure(contractions did not subside). Timepoint: day of hospitalization until the 7th day. Method of measurement: Physical exam.

Secondary

MeasureTime frame
Sever side effects(hypotension & flushing). Timepoint: Day of hospitalization until the 7th day. Method of measurement: manometer & observation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Mahin Taheri Moghadam

Ahvaz Jundishapur University of Medical Sciences

taherimoghadam-m@ajums.ac.ir+98 611336754550

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026